Annals of Hematology • Vol 104 • No 5
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study
May 2025 • Weijun Fu, Soo‐Mee Bang, Honghui Huang, Kihyun Kım, Wei Li, Gang An, Je‐Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, Chor Sang Chim, Robin Carson, Rui Li…